These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 10543444)

  • 1. On the lysosomal degradation of neurofibromin and its phosphorylation in cultured melanocytes.
    Kaufmann D; Junge I; Bartelt B; Lattke H; Müller R
    Biol Chem; 1999 Sep; 380(9):1071-8. PubMed ID: 10543444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients.
    Kaufmann D; Bartelt B; Hoffmeyer S; Müller R
    Arch Dermatol Res; 1999 Jun; 291(6):312-7. PubMed ID: 10421056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors.
    Griesser J; Kaufmann D; Maier B; Mailhammer R; Kuehl P; Krone W
    J Invest Dermatol; 1997 Mar; 108(3):275-80. PubMed ID: 9036924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells.
    Mangoura D; Sun Y; Li C; Singh D; Gutmann DH; Flores A; Ahmed M; Vallianatos G
    Oncogene; 2006 Feb; 25(5):735-45. PubMed ID: 16314845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.
    Arun V; Worrell L; Wiley JC; Kaplan DR; Guha A
    FEBS Lett; 2013 May; 587(10):1466-73. PubMed ID: 23583712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromin as a regulator of melanocyte development and differentiation.
    Diwakar G; Zhang D; Jiang S; Hornyak TJ
    J Cell Sci; 2008 Jan; 121(Pt 2):167-77. PubMed ID: 18089649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell shape normalization, dendrite orientation, and melanin production of normal and genetically altered (haploinsufficient NF1)-melanocytes by microstructured substrate interactions.
    Jungbauer S; Kemkemer R; Gruler H; Kaufmann D; Spatz JP
    Chemphyschem; 2004 Jan; 5(1):85-92. PubMed ID: 14999847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
    Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
    Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Okadaic acid increases the phosphorylation state of alpha1A-adrenoceptors and induces receptor desensitization.
    Alcántara-Hernández R; García-Sáinz JA
    Eur J Pharmacol; 2005 Nov; 525(1-3):18-23. PubMed ID: 16297906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells.
    Thomas SL; Deadwyler GD; Tang J; Stubbs EB; Muir D; Hiatt KK; Clapp DW; De Vries GH
    Biochem Biophys Res Commun; 2006 Sep; 348(3):971-80. PubMed ID: 16908010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol myristate acetate inhibits okadaic acid-induced apoptosis and downregulation of X-linked inhibitor of apoptosis in U937 cells.
    Kwon TK
    Biochem Biophys Res Commun; 2001 Sep; 287(1):135-41. PubMed ID: 11549266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
    Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
    Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromin signaling and synapses.
    Hsueh YP
    J Biomed Sci; 2007 Jul; 14(4):461-6. PubMed ID: 17370141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes.
    De Schepper S; Boucneau JM; Westbroek W; Mommaas M; Onderwater J; Messiaen L; Naeyaert JM; Lambert JL
    J Invest Dermatol; 2006 Mar; 126(3):653-9. PubMed ID: 16374483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.
    Malhotra R; Ratner N
    J Invest Dermatol; 1994 May; 102(5):812-8. PubMed ID: 8176268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
    Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
    Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the inhibition of protein degradation by insulin in L6 cells.
    Fawcett J; Hamel FG; Duckworth WC
    Arch Biochem Biophys; 2001 Jan; 385(2):357-63. PubMed ID: 11368017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12-O-tetradecanoyl-phorbol-13-acetate-dependent up-regulation of dopaminergic gene expression requires Ras and neurofibromin in human IMR-32 neuroblastoma.
    Mangoura D; Theofilopoulos S; Karouzaki S; Tsirimonaki E
    J Neurochem; 2006 Apr; 97 Suppl 1():97-103. PubMed ID: 16635257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.